The UK's largest event for private investors

Business Design Centre, London, 28 March 2020








Insilico Medicine

Insilico Medicine is an artificial intelligence company headquartered in Rockville, MD, with R&D and management resources in China, UK, Russia, Taiwan, and Korea sourced through hackathons and competitions.

The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through end-to-end drug discovery pipeline.

It specializes in generative adversarial networks, reinforcement learning, transfer learning, and meta-learning technologies.

In 2017, NVIDIA selected Insilico Medicine as one of the Top 5 AI companies for its social impact.

In 2018, Insilico was named one of the global top 100 AI companies by CB Insights. In 2018 it received the Frost & Sullivan 2018 North American Artificial Intelligence for Aging Research and Drug Development Award.

Get your ticket

Don't miss out on the UK's largest event for private investors - secure your ticket today.

Book your stand

Join us as exhibitor and get maximum exposure to around 5,000 private investors.  Increase liquidity in your company's shares, generate new leads and build your brand name in the minds of the right audience.

Check out our dedicated 'Investor Access’ microsite for more information or get in touch for a no obligation consultation.

8 + 3 =